Completed PHASE3 INTERVENTIONAL 2-arm NCT00142246

Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education.

Intermittent Preventive Treatment in Schools: a Randomised Controlled Trial of the Impact of IPT on Malaria, Anaemia and Education Amongst Schoolchildren in Western Kenya

Sponsor: London School of Hygiene and Tropical Medicine

Conditions Malaria, Falciparum

Interventions Intermittent preventive treatment (SP and amodiaquine) Placebo

Updated 6 times since 2017 Last updated: Jan 25, 2017 Started: Jan 31, 2005 Primary completion: Apr 30, 2006 Completion: Apr 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Malaria, Falciparum, this trial is completed. The trial is conducted by London School of Hygiene and Tropical Medicine and has accumulated 6 data snapshots since 2005. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

London School of Hygiene and Tropical Medicine
University of Nairobi

Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bondo, Kenya